DB Financial Investment
DB Financial Investment Building 1st and 2nd floors 32 Gukjegeumyung-ro 8-gil, Seoul, Yeongdeungpo-gu, 07331, South Korea
Overview
DB Financial Investment is a client-oriented financial investment company. Since its establishment as Citizen Investment & Finance in 1982 and its transformation into a full-scale securities company in 1991, Dongbu Securities has grown substantially along with the flourishment of the Korea capital market, and is now starting a new chapter as DB Financial Investment.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 1
Sector focus
- Finance
Investment portfolio
- NEUROPHET
Participated · Series C · Nov 2023
Neurophet develops AI-driven medical software for neurology, including brain MRI and PET analysis, stimulation simulation, and region-of-interest research tools. Its product suite includes Neurophet AQUA (brain MRI imaging analysis), Neurophet SCALE PET (brain PET scan analysis), Neurophet tES/TMS Lab (stimulation simulation), and Neurophet SegPlus (ROI research tool). The company focuses on diagnosis support, treatment guides, and treatment-device software for brain diseases using advanced AI. In November 2023 Neurophet secured KRW 20.0 billion in a Series C financing. The firm plans to use the funds to release a comprehensive Alzheimer’s dementia solution next year. The funding is intended to support continued product development and commercial rollout of its AI-driven brain imaging offerings.
Team
Wonjong Koh
President and Chief Executive Officer